These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2545322

  • 1. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
    Payment P, Trudel M, Thibodeau L, Lecomte J.
    Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP, Nikolaienko IV, Kopanytsia LV, Solohub VK, Ivanova OIe.
    Mikrobiol Z; 1997 May; 59(6):27-36. PubMed ID: 9511373
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
    Humphrey DD, Kew OM, Feorino PM.
    Infect Immun; 1982 May; 36(2):841-3. PubMed ID: 6282759
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3.
    Ferguson M, Yi-hua Q, Minor PD, Magrath DI, Spitz M, Schild GC.
    Lancet; 1982 Jul 17; 2(8290):122-4. PubMed ID: 6123838
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
    Horie H, Sato M, Doi Y, Hashizume S.
    Vaccine; 1996 Jan 17; 14(1):35-41. PubMed ID: 8821647
    [Abstract] [Full Text] [Related]

  • 13. [A comparison of the diagnostic value of the virus neutralization reaction and of indirect immunoenzyme analysis using monoclonal antibodies for the intratype differentiation of vaccinal and virulent poliovirus strains].
    Nikolaienko IV.
    Lik Sprava; 1998 May 17; (3):84-6. PubMed ID: 9695574
    [Abstract] [Full Text] [Related]

  • 14. Development of allogenic hybridomas for production of monoclonal antibodies against oral polio vaccine strains.
    Gupta CK, Sokhey J, Gupta RK, Singh H.
    Vaccine; 1991 Nov 17; 9(11):853-4. PubMed ID: 1661979
    [No Abstract] [Full Text] [Related]

  • 15. Natural variation of poliovirus neutralization epitopes.
    Crainic R, Couillin P, Blondel B, Cabau N, Boué A, Horodniceanu F.
    Infect Immun; 1983 Sep 17; 41(3):1217-25. PubMed ID: 6193066
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antigenic characterization of poliovirus type 3 using monoclonal antibodies.
    Ferguson M, Minor PD, Magrath DI, Spitz M, Schild GC.
    Rev Infect Dis; 1984 Sep 17; 6 Suppl 2():S510-3. PubMed ID: 6204368
    [Abstract] [Full Text] [Related]

  • 18. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M, Minor PD, Magrath DI, Schild GC.
    Dev Biol Stand; 1984 Sep 17; 57():151-5. PubMed ID: 6098495
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.
    Taniguchi K, Urasawa S, Urasawa T.
    J Gen Virol; 1985 May 17; 66 ( Pt 5)():1045-53. PubMed ID: 2987395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.